Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The basis for updates for the 9th edition of UICC TNM classification of malignant diseases

Prof James Brierley - University of Toronto, Toronto, Canada
The basis for updates for the 9th edition of UICC TNM classification of malignant diseases ( Prof James Brierley - University of Toronto, Toronto, Canada )
11 Nov 2026

Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does not improve OS

Dr Wungki Park - Memorial Sloan Kettering Cancer Center, New York, USA
Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does not improve OS ( Dr Wungki Park - Memorial Sloan Kettering Cancer Center, New York, USA )
6 Jul 2026

ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas

Dr Kozo Kataoka - Hyogo Medical University, Nishinomiya, Japan
ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas ( Dr Kozo Kataoka - Hyogo Medical University, Nishinomiya, Japan )
6 Jul 2026

Defining breast cancer quality care around the globe

Dr Didier Verhoeven, Prof Sabine Siesling, Prof Pankaj Gupta Roy & Prof Cary Kaufman
Defining breast cancer quality care around the globe ( Dr Didier Verhoeven, Prof Sabine Siesling, Prof Pankaj Gupta Roy & Prof Cary Kaufman )
1 Jul 2026

Novel therapies in mCRPC: Tarlatamab targeting DLL3 shows early activity in neuroendocrine mCRPC

Dr Rahul Aggarwal - University of California, San Francisco, USA
Novel therapies in mCRPC: Tarlatamab targeting DLL3 shows early activity in neuroendocrine mCRPC ( Dr Rahul Aggarwal - University of California, San Francisco, USA )
26 Jun 2026

Highlights from APCCC 2026

Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina
Highlights from APCCC 2026 ( Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina )
24 Jun 2026

Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy

Dr Minit Shah - Tata Memorial Centre, Mumbai, India
Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy ( Dr Minit Shah - Tata Memorial Centre, Mumbai, India )
17 Jun 2026

Development and challenges for T-cell engagers as a novel treatment for lung cancer and mesothelioma

Dr May-Lucie Meyer - Lausanne University Hospital, Lausanne, Switzerland
Development and challenges for T-cell engagers as a novel treatment for lung cancer and mesothelioma ( Dr May-Lucie Meyer - Lausanne University Hospital, Lausanne, Switzerland )
16 Apr 2026

Education and training in breast cancer care

Dr Alexandru Eniu, Danny Burke & Dr Montassar Ghalleb
Education and training in breast cancer care ( Dr Alexandru Eniu, Danny Burke & Dr Montassar Ghalleb )
14 Apr 2026

QoL outcomes are inconsistently reported in contemporary phase III genitourinary cancer trials

Dr Shreyas Kalantri - University of Louisville, Louisville
QoL outcomes are inconsistently reported in contemporary phase III genitourinary cancer trials ( Dr Shreyas Kalantri - University of Louisville, Louisville )
17 Mar 2026

The Vanessa Moss Prize: celebrating research into cancer health disparities

Dr Olubukola Ayodele - University Hospitals of Leicester NHS Trust, Leicester, UK
The Vanessa Moss Prize: celebrating research into cancer health disparities ( Dr Olubukola Ayodele - University Hospitals of Leicester NHS Trust, Leicester, UK )
16 Feb 2026

Can public–private partnerships accelerate cancer research and clinical trials in LMICs?

Prof Ahmed Hassan Abdel Aziz - Ain Shams University, Cairo, Egypt
Can public–private partnerships accelerate cancer research and clinical trials in LMICs? ( Prof Ahmed Hassan Abdel Aziz - Ain Shams University, Cairo, Egypt )
5 Feb 2026